Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-29

FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Solco Healthcare US LLC)

View source ↗

Summary

FDA approved a supplemental application for Bupropion Hydrochloride sustained-release from Solco Healthcare US LLC, indicating approval of a modification to an …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)